“…Photoactivatable compounds (2a-f) were designed to display CA inhibition, synthesized for the treatment of microbial infections, and assayed against several isoforms of bacterial carbonic anhydrase, displaying good selectivity compared with that to off-target human CAs I and II. In particular, derivatives 2a, 2b, and 2f showed moderate to good antibacterial activity against Gram-positive bacteria such as E. faecalis, S. aureus, and S. epidermidis, as also recently demonstrated in Gram-negative bacteria by other chemical scaffolds [25,26]. When these compounds were irradiated with a 652 nm laser, except for compound 2e, at least 1 log of growth reduction was observed for S. epidermidis and, notably, 2 log of growth reduction with compound 2b.…”